936 results on '"Liang, Chaozhao"'
Search Results
2. Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019
3. Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction
4. The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis
5. Overexpression of DDX49 in prostate cancer is associated with poor prognosis
6. TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies
7. Radial Extracorporeal Shock Wave Therapy Combined with Resveratrol Derivative Alleviates Chronic Nonbacterial Prostatitis in Rats
8. Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy
9. Nomogram for predicting risk factors of fever in patients with negative preoperative urine culture after retrograde intrarenal surgery
10. Obacunone alleviates chronic pelvic pain and pro-inflammatory depolarization of macrophage induced by experimental autoimmune prostatitis in mice
11. Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer
12. Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
13. Patient-reported outcomes (PROs) for rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy (ADT) in high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC): An analysis of the CHART randomized, open-label, phase 3 trial.
14. Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway
15. Clinical outcomes and risk factors for mortality in recipients with carbapenem-resistant gram-negative bacilli infections after kidney transplantation treated with ceftazidime-avibactam: a retrospective study
16. The causative effect of CXCR7 on experimental autoimmune prostatitis injury and fibrosis
17. Cigarette smoking and risk of bladder cancer: a dose–response meta-analysis
18. Effects of alternative splicing events and transcriptome changes on kidney stone formation
19. Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
20. Risk subtyping and prognostic assessment of prostate cancer based on consensus genes
21. Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in male mice
22. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
23. Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
24. Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour
25. NLRP3-mediated IL-1β in regulating the imbalance between Th17 and Treg in experimental autoimmune prostatitis.
26. Dual deficiency of melatonin and dihydrotestosterone promotes stromal cell damage and mediates prostatitis via the cGAS-STING pathway in sleep-deprived mice
27. Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway
28. HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma
29. Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction
30. Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis
31. Effect of preservation fluid contamination and associated possible donor-derived infections on early postoperative prognosis in kidney transplant recipients.
32. MED15 is upregulated by HIF-2α and promotes proliferation and metastasis in clear cell renal cell carcinoma via activation of SREBP-dependent fatty acid synthesis.
33. Oxygen-enriched Fe3O4/Gd2O3 nanopeanuts for tumor-targeting MRI and ROS-triggered dual-modal cancer therapy through platinum (IV) prodrugs delivery
34. Elucidating the interplay between prostate cancer, education, and fat intake through causal inference and mediation analysis
35. 4‐Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome‐induced pyroptosis through activating Nrf2/HO‐1 pathway
36. Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
37. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy
38. Alterations in urinary microbiota composition in urolithiasis patients: insights from 16S rRNA gene sequencing
39. Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?
40. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
41. A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma
42. Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
43. N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8
44. Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease
45. Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis
46. A genomic and epigenomic atlas of prostate cancer in Asian populations
47. Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
48. The clinical value of the prostatic exosomal protein expression in the diagnosis of chronic prostatitis: a single-center study
49. Experimental Autoimmune Prostatitis Induces Learning-Memory Impairment and Structural Neuroplastic Changes in Mice
50. The Hypermethylation of Foxp3 Promoter Impairs the Function of Treg Cells in EAP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.